←
David Healey140 posts
David Healey avatar

David Healey

@davidwhealey

VP Data Science at Enveda Biosciences. ML for drug discovery. Formerly at Recursion & MIT.

◷ Joined December 2010▧ 4 Photos and videos
Kaggle avatar
⟳ David Healey retweeted
Kaggle@kaggle·Sep 15

Mass spectrometry detects thousands of molecules in nature, but most remain unidentified. 🌿 Join the Enveda CASMI 2026 - Molecule ID From Mass Spectra Competition, hosted by @enveda and Kaggle, to build machine learning models that predict 2-D chemical structures from LC-MS/MS spectra. • Prize Pool: $50,000 • Entry Deadline: December 7, 2026

Enveda avatar
⟳ David Healey retweeted
Enveda@enveda·Sep 15

Like the protein folding competition that led to AlphaFold, Enveda just launched CASMI 2026, aimed at one of science’s biggest unsolved challenges. #CASMI26 is Enveda’s 90-day Kaggle competition challenging AI and machine learning researchers across the globe to develop new ways to identify the vast majority of nature’s chemistry that remains a mystery. Open through December 14, with $50,000 in prizes. Learn more about the Critical Assessment of Small Molecule Identification (CASMI) competition: businesswire.com/news/home/2…. #Chemistry #Biology #Science

0:06
David Healey avatar
David Healey@davidwhealey·Jun 2

Metabolomics folks: if you're at #ASMS, stop by Enveda's posters to get sneak peeks of our impending data drop and our upcoming public CASMI small molecule identification competition! Wednesday: WP 439 (Enveda-180 dataset) hursday: ThP 341 (CASMI 2016)

Robert Gehrke avatar
⟳ David Healey retweeted
Robert Gehrke@RobertGehrke·Mar 27

There is a LOT of stuff to unpack in Todd's thread here. So let's break it down, shall we? It is true that about 220k people signed the petition. About 30% were invalid. Another ~9K removed their signatures. That was the tally over about 100 days of signature gathering. The ..

1/. I want to recognize the incredible efforts of over 218,000 Utahns who stood up to protect the integrity of our representative government. While a narrow margin of removals in a single senate district has kept this initiative off the ballot, the sheer volume of support—

Nathan Benaich avatar
⟳ David Healey retweeted
Nathan Benaich@nathanbenaich·3 Dec 2024

News! @modal_labs is supporting @RAAIS fellowships with $10,000 credits on their platform, alongside the $5,000 GPU credits from @LambdaAPI. Working on AI-first, open source research outside big institutions? Apply at airstreet(dot)com/fellowships

Post attachment

News! We’re delighted to announce that applications are open for a new batch of @RAAIS fellowships - provided support to AI-first, open source research outside big institutions. Apply at airstreet(dot)com/fellowships Many thanks to our partners @LambdaAPI for their support.

1:54
David Healey avatar
David Healey@davidwhealey·11 Jul 2024

Walking around the cathedral in #rouen around noon today and suddenly the spire was burning.

0:16
David Healey avatar
David Healey@davidwhealey·2 Jun 2024

Mass spectrometry people, if you're at #ASMS this year, come see my talk at the Bruker eXceed symposium Multiomics breakout session Sunday at 12 noon, I'll be talking about our new PRISM foundation model.

andrew blevins avatar
⟳ David Healey retweeted
andrew blevins@Andrewdblevins·4 Apr 2024

Working on ML for Drug Discovery I have been frustrated with the size and/or quality of publicly available datasets to train and benchmark models with, so when my co-founder and I started our company we swore we would open-source some data as quickly as possible.

Nathan Benaich avatar
⟳ David Healey retweeted
Nathan Benaich@nathanbenaich·12 Oct 2023

🪩The @stateofai 2023 is now here. Our 6th installment is one of the most exciting years I can remember. The #stateofai report covers everything you *need* to know, covering research, industry, safety and politics. There’s lots in there, so here’s my director’s cut 🧵

Post attachment
Enveda avatar
⟳ David Healey retweeted
Enveda@enveda·27 Sep 2023

We’re grateful to @ClarivateHealth for recognizing us as a leader in using innovative #AI #ML technologies to upend the drug discovery and development paradigm in their annual “Companies to Watch” report! clarivate.com/lp/companies-t…

Post attachment
Enveda avatar
⟳ David Healey retweeted
Enveda@enveda·21 Sep 2023

We are proud to be selected by the @endpts editorial team as one of the most promising and ambitious #biotech startups! We’re grateful for the recognition of what we’ve built so far and where we are headed next: the clinic in 2024! endpts.com/the-endpoints-11-…

Post attachment
David Healey avatar
David Healey@davidwhealey·21 Jun 2023

MS2Mol preprint is out! De novo structure prediction of molecules from mass spectra!

Enveda@enveda21 Jun 2023

📰Pre-print alert!📰 It is with great pride and excitement that we share the details of our latest AI model, MS2Mol, to unlock nature’s chemical code. Read on to learn more about the tech and how we use it to translate the language of chemistry 🧵👇 /1

1:02